We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
-18.72%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$852M
AUM Growth
-$2.71B
Cap. Flow
-$2.35B
Cap. Flow %
-275.82%
Top 10 Hldgs %
41.33%
Holding
1,001
New
100
Increased
48
Reduced
168
Closed
613

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$24.8M
2
BHC icon
Bausch Health
BHC
+$12.4M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$12.3M
4
NFLX icon
Netflix
NFLX
+$10.3M
5
TNET icon
TriNet
TNET
+$9.7M

Sector Composition

Rank Sector Weight
1 Healthcare 1.87%
2 Energy 1.43%
3 Technology 0.91%
4 Real Estate 0.26%
5 Communication Services 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
126
PUT
Procter & Gamble
PG
$335B
$1.03M 0.12%
+7,200
New +$1.08M
PTGX icon
127
CALL
Protagonist Therapeutics
PTGX
$8.68B
$1.01M 0.12%
128,000
+7,500
+6% +$90.7K
KRTX
128
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.01M 0.12%
+8,000
New +$919K
INMD icon
129
InMode
INMD
$870M
$1.01M 0.12%
+45,000
New +$1.18M
DFS
130
PUT
DELISTED
Discover Financial Services
DFS
$1M 0.12%
10,600
TBCH
131
PUT
Turtle Beach Corp
TBCH
$242M
$978K 0.11%
80,000
-230,100
-74% -$3.92M
PRGO icon
132
CALL
Perrigo
PRGO
$1.41B
$974K 0.11%
24,000
-2,300
-9% -$85.4K
NBIS
133
Nebius Group N.V.
NBIS
$46.9B
$972K 0.11%
51,300
ONC
134
CALL
BeOne Medicines Ltd
ONC
$32.6B
$971K 0.11%
6,000
-9,000
-60% -$1.41M
NOK icon
135
CALL
Nokia
NOK
$50.9B
$968K 0.11%
210,000
-29,000
-12% -$145K
ACAD icon
136
Acadia Pharmaceuticals
ACAD
$4.36B
$909K 0.11%
64,500
+6,463
+11% +$121K
ACAD icon
137
PUT
Acadia Pharmaceuticals
ACAD
$4.36B
$909K 0.11%
64,500
-6,000
-9% -$112K
IVR icon
138
CALL
Invesco Mortgage Capital
IVR
$750M
$895K 0.11%
61,000
+54,900
+900% +$927K
AAL icon
139
PUT
American Airlines Group
AAL
$10.1B
$894K 0.11%
70,500
-279,500
-80% -$4.65M
TWLO icon
140
CALL
Twilio
TWLO
$29.5B
$888K 0.1%
10,600
-57,100
-84% -$6.39M
DVA icon
141
CALL
DaVita
DVA
$15.3B
$880K 0.1%
11,000
-9,000
-45% -$911K
Z icon
142
PUT
Zillow
Z
$7.67B
$876K 0.1%
27,600
-209,400
-88% -$8.41M
AMD icon
143
CALL
Advanced Micro Devices
AMD
$797B
$872K 0.1%
11,400
+7,400
+185% +$693K
FLNA
144
PUT
Filana Therapeutics
FLNA
$48.3M
$872K 0.1%
31,000
-115,900
-79% -$2.93M
W icon
145
CALL
Wayfair
W
$11.5B
$871K 0.1%
20,000
BKR icon
146
PUT
Baker Hughes
BKR
$60B
$866K 0.1%
30,000
+5,000
+20% +$169K
KLIC icon
147
CALL
Kulicke & Soffa
KLIC
$4.72B
$856K 0.1%
20,000
BMRN icon
148
BioMarin Pharmaceuticals
BMRN
$11.5B
$854K 0.1%
10,300
-1,700
-14% -$135K
SRI icon
149
Stoneridge
SRI
$193M
$840K 0.1%
49,000
-1,000
-2% -$19K
HR icon
150
CALL
Healthcare Realty
HR
$7.32B
$837K 0.1%
30,000
-108,000
-78% -$3.21M

Similar funds

SG3 Management's Q2 2022 Portfolio in Review

As of Q2 2022, SG3 Management held 1,001 positions worth $852M, down 76% from $3.56B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

SG3 Management withdrew a net $2.35B in Q2 2022, closing 613 positions and reducing 168 holdings. Its most notable exit was Amazon, an estimated $24.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, down from 2.5% a quarter earlier, followed by Energy and Technology.

Against the trend, SG3 Management opened a new position in KraneShares CSI China Internet ETF worth $6.55M.

  • SG3 Management's largest Q2 2022 buy was KraneShares CSI China Internet ETF: 200,000 shares worth $6.55M.
  • SG3 Management added most to Revolve Group in Q2 2022, an estimated $665K increase.
  • SG3 Management's biggest Q2 2022 reduction was Bausch Health, cutting an estimated $12.4M.
  • SG3 Management fully exited Amazon in Q2 2022, selling an estimated $24.8M.
  • SG3 Management's ten largest holdings make up 41% of its $852M portfolio in Q2 2022.
  • SG3 Management opened 100 new positions and closed 613 in Q2 2022.
  • SG3 Management's portfolio value fell 76% quarter-over-quarter to $852M.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.